Jennifer J. Kiser

5.5k total citations
107 papers, 3.5k citations indexed

About

Jennifer J. Kiser is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Jennifer J. Kiser has authored 107 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Infectious Diseases, 38 papers in Virology and 29 papers in Hepatology. Recurrent topics in Jennifer J. Kiser's work include HIV/AIDS drug development and treatment (72 papers), HIV/AIDS Research and Interventions (40 papers) and HIV Research and Treatment (37 papers). Jennifer J. Kiser is often cited by papers focused on HIV/AIDS drug development and treatment (72 papers), HIV/AIDS Research and Interventions (40 papers) and HIV Research and Treatment (37 papers). Jennifer J. Kiser collaborates with scholars based in United States, Netherlands and South Africa. Jennifer J. Kiser's co-authors include Peter L. Anderson, Lane R. Bushman, José Castillo‐Mancilla, Jia‐Hua Zheng, Joseph E. Rower, Edward M. Gardner, Gregory T. Everson, Amie L. Meditz, James R. Burton and Courtney V. Fletcher and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Jennifer J. Kiser

102 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer J. Kiser United States	32	2.5k	1.3k	1.1k	585	403	107	3.5k
Lane R. Bushman United States	30	2.7k 1.1×	1.2k 1.0×	1.3k 1.3×	188 0.3×	247 0.6×	97	3.5k
Gilles Peytavin France	40	4.8k 1.9×	1.2k 1.0×	3.7k 3.5×	618 1.1×	872 2.2×	267	6.3k
Marc van der Valk Netherlands	39	2.6k 1.0×	1.6k 1.3×	1.9k 1.8×	1.0k 1.7×	1.3k 3.3×	212	4.6k
Marta Boffito United Kingdom	37	3.4k 1.3×	1.0k 0.8×	2.0k 1.9×	229 0.4×	1.1k 2.7×	253	4.6k
Chloe Orkin United Kingdom	39	3.8k 1.5×	1.8k 1.4×	2.7k 2.6×	885 1.5×	1.8k 4.4×	168	6.0k
Laura Smeaton United States	28	2.1k 0.8×	722 0.6×	1.5k 1.5×	277 0.5×	636 1.6×	75	2.8k
Maria Jesús Pérez‐Elías Spain	29	2.4k 0.9×	1.1k 0.8×	1.7k 1.6×	499 0.9×	786 2.0×	179	3.4k
Karam Mounzer United States	30	1.4k 0.5×	974 0.8×	1.4k 1.3×	416 0.7×	471 1.2×	117	3.0k
Brian P. Kearney United States	40	3.9k 1.6×	1.1k 0.9×	2.4k 2.3×	698 1.2×	843 2.1×	93	5.1k
Ferdinand W.N.M. Wit Netherlands	34	2.2k 0.9×	1.0k 0.8×	1.8k 1.7×	362 0.6×	1.5k 3.7×	109	3.6k

Countries citing papers authored by Jennifer J. Kiser

Since Specialization

Citations

This map shows the geographic impact of Jennifer J. Kiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer J. Kiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer J. Kiser more than expected).

Fields of papers citing papers by Jennifer J. Kiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer J. Kiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer J. Kiser. The network helps show where Jennifer J. Kiser may publish in the future.

Co-authorship network of co-authors of Jennifer J. Kiser

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer J. Kiser. A scholar is included among the top collaborators of Jennifer J. Kiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer J. Kiser. Jennifer J. Kiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Branchford, Brian R., Travis Nemkov, B. D. Johnson, et al.. (2025). Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV. Journal of Antimicrobial Chemotherapy. 80(5). 1224–1232.

Zhang, Helen L., et al.. (2024). Cumulative Tenofovir Exposure Among Patients With HIV/Hepatitis B Coinfection With Differential Viral Suppression. Clinical Infectious Diseases. 79(3). 705–708. 1 indexed citations

Chappell, Catherine A., Jennifer J. Kiser, Kristina M. Brooks, et al.. (2024). Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus. Clinical Infectious Diseases. 80(4). 744–751. 2 indexed citations

Bushman, Lane R., et al.. (2023). Development and validation of an LC-MS/MS method to quantify the alcohol biomarker phosphatidylethanol 16:0/18:1 in dried blood spots for clinical research purposes. Journal of Chromatography B. 1223. 123725–123725.

Morrow, Mary, Samantha MaWhinney, Stacey S. Coleman, et al.. (2022). Cumulative tenofovir diphosphate exposure in persons with HIV taking single‐ vs. multiple‐tablet regimens. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(8). 641–650.

Kiser, Jennifer J., et al.. (2022). New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus. Antimicrobial Agents and Chemotherapy. 66(12). e0122622–e0122622. 35 indexed citations

Ibrahim, Mustafa E., José Castillo‐Mancilla, Kristina M. Brooks, et al.. (2020). Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis. AIDS Research and Human Retroviruses. 37(6). 421–428. 10 indexed citations

Castillo‐Mancilla, José, Stacey S. Coleman, Mary Morrow, et al.. (2019). Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIV. AIDS Research and Human Retroviruses. 36(3). 173–175. 4 indexed citations

Seifert, Sharon M., Xinhui Chen, Amie L. Meditz, et al.. (2016). Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State. AIDS Research and Human Retroviruses. 32(10-11). 981–991. 67 indexed citations

10.

Zheng, Jia‐Hua, José Castillo‐Mancilla, Brandon Klein, et al.. (2016). Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. Journal of Pharmaceutical and Biomedical Analysis. 122. 16–20. 96 indexed citations

11.

Rower, Joseph E., James R. Burton, Peter L. Anderson, et al.. (2015). Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy. 59(4). 2179–2188. 25 indexed citations

12.

Kiser, Jennifer J., James R. Burton, & Gregory T. Everson. (2013). Drug–drug interactions during antiviral therapy for chronic hepatitis C. Nature Reviews Gastroenterology & Hepatology. 10(10). 596–606. 105 indexed citations

13.

Castillo‐Mancilla, José, Jia‐Hua Zheng, Joseph E. Rower, et al.. (2012). Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure. AIDS Research and Human Retroviruses. 29(2). 384–390. 239 indexed citations

14.

Kiser, Jennifer J., et al.. (2012). Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz. Infectious Diseases in Obstetrics and Gynecology. 2012. 1–4. 48 indexed citations

15.

Bushman, Lane R., Jennifer J. Kiser, Joseph E. Rower, et al.. (2011). Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detection. Journal of Pharmaceutical and Biomedical Analysis. 56(2). 390–401. 91 indexed citations

16.

Henderson, Kevin, Jason T. Hindman, Steven C. Johnson, Robert J. Valuck, & Jennifer J. Kiser. (2011). Assessing the Effectiveness of Pharmacy-Based Adherence Interventions on Antiretroviral Adherence in Persons with HIV. AIDS Patient Care and STDs. 25(4). 221–228. 61 indexed citations

17.

Kiser, Jennifer J., Richard M. Rutstein, Pearl Samson, et al.. (2011). Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. AIDS. 25(12). 1489–1496. 17 indexed citations

18.

Kiser, Jennifer J., et al.. (2008). Clinical and Genetic Determinants of Intracellular Tenofovir Diphosphate Concentrations in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(3). 298–303. 117 indexed citations

19.

Stearns, Lisa, Richard L. Boortz-Marx, Stuart Du Pen, et al.. (2006). Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.. PubMed. 3(6). 399–408. 78 indexed citations

20.

Kakuda, Thomas N. & Jennifer J. Kiser. (2006). 7th International Workshop on Clinical Pharmacology of HIV Therapy. Expert Opinion on Pharmacotherapy. 7(11). 1519–1533. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact